Sign in
Taking people in United StatesNo phase

Vaped Phenanthrene

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
1 Sept 2026
Expected to end
30 Jun 2028
Type of study
Interventional
Treatments tested
  • D10-phenanthrene
Record updated
3 September 2026

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • > 21 years of age
  • In good physical \& mental health
  • In stable physical \& mental health
  • Have tried vaping
  • Former daily cigarette smokers who quit 1-20 year ago
  • Non-smokers who have not used tobacco or nicotine products

Who cannot take part

  • Has experience negative effects when vaped previously
  • Has any respiratory disease (ex - asthma, COPD, etc...)
  • Has/had liver disease
  • Has/had cancer
  • Has/had high blood pressure
  • Pregnant or nursing

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Aleksandra AlchevaTaking people

About the trial

What the trial wants to find out

Some people who used to smoke cigarettes continue to be at higher risk of developing lung cancer, even years after quitting. This study will look to see if a specific chemical, phenanthrene, is broken down in the lungs of former smokers through more harmful pathways than never-smokers. If former smokers break down chemicals that enter their lungs through more harmful pathways this might be putting them at higher risk for developing lung cancer even though they quit smoking. This information may help find better ways to prevent or treat cancer in the future.

Read full original descriptionShow less

This study is under an IND, but the drug is not being studied; instead, it is being used as a marker for drug metabolism.

The group in the trial

  • D10-phenanthreneOther group

    All study participants (Former Daily Smokers and Non-smokers) will be asked to vape D10-phenanthrene to see how their lungs breakdown a class of cancer-causing chemicals known as polycyclic aromatic hydrocarbons \[PAHs\].

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Investigating Vaped Phenanthrene Biomarkers in Former Smokers
Record updated
3 September 2026